Shalini Bansil

Dr. Shalini Bansil serves as Associate Professor in the Department of Neurology Division of Stroke at University of Medicine and Dentistry of New Jersey (New Jersey Medical School). Board-certified in both Neurology (1989-present) and Vascular Neurology (2006-present) by the American Board of Psychiatry and Neurology, she maintains active clinical and research roles.

Education:

• Stroke and Neuro-Critical Care Fellowship, Mount Sinai Beth Israel (1998)
• Neuroimmunology and Multiple Sclerosis Fellowship, UMDNJ-New Jersey Medical School (1988-1990)
• Neurology Residency, UMDNJ-New Jersey Medical School (1985-1987)
• Medical Internship, UMDNJ-New Jersey Medical School (1984-1985)
• Rotating Internship, Christian Medical College (1982-1983)
• MBBS, Medicine and Surgery, Christian Medical College (1977-1981)

Her research focuses on clinical stroke outcomes across acute/subacute/chronic phases, with particular emphasis on telemedicine applications for quality improvement. She investigates stroke prevention strategies including community-based atrial fibrillation detection systems to reduce recurrent events. Complementing this, her work spans demyelinating diseases with significant contributions to multiple sclerosis research through neuroimaging biomarkers and hormonal influences on disease progression. The fingerprint analysis confirms deep expertise in Progressive Multiple Sclerosis (29%), MRI applications (24%), and T-cell immunology (22%).

Publication trends reveal an evolution from MS-focused clinical trials (1990s-2000s) toward stroke systems research (2000s-2010s), demonstrating methodological versatility across clinical outcome measurement, cardiac monitoring integration, and telehealth implementation. Her work contributes to UN Sustainable Development Goals through neurological health improvement initiatives.

Professional recognition includes an h-index of 15 with 639 Scopus citations, reflecting substantial scholarly impact across neurology and stroke care domains.

Dr. Bansil's clinical practice centers on hyperacute stroke treatment and prevention strategies, while her research program bridges telemedicine innovation with traditional neurological care pathways. Her work demonstrates consistent NIH-level research activity since 1990 with 23 total publications spanning high-impact journals including Journal of Stroke and Cerebrovascular Diseases and Multiple Sclerosis.

Current research networks indicate active collaboration in stroke care systems and MS therapeutics, with recent work referenced in 10 patents and policy documents reflecting translational impact.